Weight-loss drug firm accused of prioritising profits after halting insulin pen production

ICYMI: Novo Nordisk’s decision will force people in developing countries to use outdated glass vials and syringes, warn campaigners The pharmaceutical company behind injectable weight-loss drugs has been accused of prioritising profits over the health of people in developing countries by halting production of human insulin in pens. People living with type 1 diabetes who […]
http://dlvr.it/TFjJ9h